Journal of Clinical Oncology, 38(15). American Society of Clinical Oncology Planchard, D, Besse, B, Groen, H, Hashemi, S, Mazieres, J, Kim, T M, Quoix, E A, Souquet, P J, Barlesi, F, Baik, C S, Villaruz, L C, Kelly, R J, Zhang, S, Tan, M, Gasal, E, Santarpia, L & Johnson, B E 2020, ' Updated overall survival (OS) and genomic analysis from a single-arm phase II study of dabrafenib (D) plus trametinib (T) in patients (pts) with BRAF V600E mutant (Mut) metastatic non-small cell lung cancer (NSCLC). ', Journal of Clinical Oncology, vol. 38, no. 15 . Journal of Clinical Oncology, 38(15). AMER SOC CLINICAL ONCOLOGY